Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Molecular Pathogenesis of Gene Regulation by the miR-150 Duplex: miR-150-3p Regulates TNS4 in Lung Adenocarcinoma.

Misono S, Seki N, Mizuno K, Yamada Y, Uchida A, Sanada H, Moriya S, Kikkawa N, Kumamoto T, Suetsugu T, Inoue H.

Cancers (Basel). 2019 Apr 30;11(5). pii: E601. doi: 10.3390/cancers11050601.

2.

Regulation of KIF2A by Antitumor miR-451a Inhibits Cancer Cell Aggressiveness Features in Lung Squamous Cell Carcinoma.

Uchida A, Seki N, Mizuno K, Yamada Y, Misono S, Sanada H, Kikkawa N, Kumamoto T, Suetsugu T, Inoue H.

Cancers (Basel). 2019 Feb 22;11(2). pii: E258. doi: 10.3390/cancers11020258.

3.

Involvement of dual-strand of the miR-144 duplex and their targets in the pathogenesis of lung squamous cell carcinoma.

Uchida A, Seki N, Mizuno K, Misono S, Yamada Y, Kikkawa N, Sanada H, Kumamoto T, Suetsugu T, Inoue H.

Cancer Sci. 2019 Jan;110(1):420-432. doi: 10.1111/cas.13853. Epub 2018 Dec 6.

4.

Inhibition of integrin β1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma.

Koshizuka K, Kikkawa N, Hanazawa T, Yamada Y, Okato A, Arai T, Katada K, Okamoto Y, Seki N.

Oncotarget. 2017 Dec 11;9(3):3663-3676. doi: 10.18632/oncotarget.23194. eCollection 2018 Jan 9.

5.

Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.

Koshizuka K, Hanazawa T, Kikkawa N, Katada K, Okato A, Arai T, Idichi T, Osako Y, Okamoto Y, Seki N.

Auris Nasus Larynx. 2018 Aug;45(4):854-865. doi: 10.1016/j.anl.2017.11.019. Epub 2017 Dec 9.

PMID:
29233721
6.

Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.

Yamada Y, Koshizuka K, Hanazawa T, Kikkawa N, Okato A, Idichi T, Arai T, Sugawara S, Katada K, Okamoto Y, Seki N.

Int J Oncol. 2018 Jan;52(1):166-178. doi: 10.3892/ijo.2017.4190. Epub 2017 Nov 6.

7.

Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma.

Koshizuka K, Hanazawa T, Arai T, Okato A, Kikkawa N, Seki N.

Cancer Metastasis Rev. 2017 Sep;36(3):525-545. doi: 10.1007/s10555-017-9692-y. Review.

PMID:
28836104
8.

Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.

Koshizuka K, Hanazawa T, Kikkawa N, Arai T, Okato A, Kurozumi A, Kato M, Katada K, Okamoto Y, Seki N.

Cancer Sci. 2017 Aug;108(8):1681-1692. doi: 10.1111/cas.13298. Epub 2017 Jul 4.

9.

Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.

Koshizuka K, Nohata N, Hanazawa T, Kikkawa N, Arai T, Okato A, Fukumoto I, Katada K, Okamoto Y, Seki N.

Oncotarget. 2017 May 2;8(18):30288-30304. doi: 10.18632/oncotarget.16327.

10.

The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.

Fukumoto I, Koshizuka K, Hanazawa T, Kikkawa N, Matsushita R, Kurozumi A, Kato M, Okato A, Okamoto Y, Seki N.

Int J Oncol. 2016 Sep;49(3):1119-29. doi: 10.3892/ijo.2016.3602. Epub 2016 Jul 4.

PMID:
27573718
11.

The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Koshizuka K, Hanazawa T, Fukumoto I, Kikkawa N, Okamoto Y, Seki N.

J Hum Genet. 2017 Jan;62(1):3-13. doi: 10.1038/jhg.2016.105. Epub 2016 Aug 25. Review.

PMID:
27557665
12.

Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.

Koshizuka K, Hanazawa T, Fukumoto I, Kikkawa N, Matsushita R, Mataki H, Mizuno K, Okamoto Y, Seki N.

J Hum Genet. 2017 Jan;62(1):113-121. doi: 10.1038/jhg.2016.47. Epub 2016 May 12.

PMID:
27169691
13.

Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.

Fukumoto I, Kikkawa N, Matsushita R, Kato M, Kurozumi A, Nishikawa R, Goto Y, Koshizuka K, Hanazawa T, Enokida H, Nakagawa M, Okamoto Y, Seki N.

J Hum Genet. 2016 Feb;61(2):109-18. doi: 10.1038/jhg.2015.120. Epub 2015 Oct 22.

PMID:
26490187
14.

microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.

Kikkawa N, Kinoshita T, Nohata N, Hanazawa T, Yamamoto N, Fukumoto I, Chiyomaru T, Enokida H, Nakagawa M, Okamoto Y, Seki N.

Int J Oncol. 2014 Jun;44(6):2085-92. doi: 10.3892/ijo.2014.2349. Epub 2014 Mar 19.

PMID:
24647829
15.

Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.

Kinoshita T, Hanazawa T, Nohata N, Kikkawa N, Enokida H, Yoshino H, Yamasaki T, Hidaka H, Nakagawa M, Okamoto Y, Seki N.

Oncotarget. 2012 Nov;3(11):1386-400.

16.

Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.

Kinoshita T, Nohata N, Fuse M, Hanazawa T, Kikkawa N, Fujimura L, Watanabe-Takano H, Yamada Y, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N.

Biochem Biophys Res Commun. 2012 Feb 10;418(2):378-83. doi: 10.1016/j.bbrc.2012.01.030. Epub 2012 Jan 12.

PMID:
22266319
17.

Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma.

Kinoshita T, Nohata N, Yoshino H, Hanazawa T, Kikkawa N, Fujimura L, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Okamoto Y, Seki N.

Int J Oncol. 2012 Jan;40(1):185-93. doi: 10.3892/ijo.2011.1196. Epub 2011 Sep 12.

PMID:
21922130
18.

Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).

Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Sakurai D, Fujimura L, Kawakami K, Chiyomaru T, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N.

J Hum Genet. 2011 Aug;56(8):595-601. doi: 10.1038/jhg.2011.66. Epub 2011 Jul 14.

PMID:
21753766
19.

Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma.

Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Sasaki K, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N.

Int J Oncol. 2011 Nov;39(5):1099-107. doi: 10.3892/ijo.2011.1096. Epub 2011 Jun 23.

PMID:
21701775
20.

miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma.

Nohata N, Sone Y, Hanazawa T, Fuse M, Kikkawa N, Yoshino H, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Shozu M, Okamoto Y, Seki N.

Oncotarget. 2011 Jan-Feb;2(1-2):29-42.

Supplemental Content

Loading ...
Support Center